Granulocyte colony-stimulating factor therapy reduces hospitalizations and improves chemotherapy administration in elderly breast cancer patients, but increases overall Medicare costs during first year of therapy.
Sally C. Stearns, PhD
Advertisement
Articles by Sally C. Stearns, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About Retatrutide, the "Trillion-Dollar" Drug
2
Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care
3
GLP-1 Use Remains Rare Among Eligible Patients With Multiple Sclerosis
4
ICER Draft Flags High Cost of New Hypertension Drug Class
5